Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...

Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

Despite these clinical milestones and ongoing innovation, including first-in-human studies of new oncology drugs, Pfizer Inc.

Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. I won't rehash Pfizer's pandemic journey too much. The company developed and sold a vaccine (Comirnaty) ...

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...

Right-wing podcaster Joe Rogan thinks “Pfizer alone” may have killed off more people than World War I, World War II, and ...

A new Covid variant, NB.1.8.1, is detected in US airports. The variant is driving a surge in cases across China. Cases are ...

Astellas & Pfizer’s Xtandi shows long-term overall survival in metastatic hormone-sensitive prostate cancer: Tokyo Saturday, May 24, 2025, 13:00 Hrs [IST] Astellas Pharma Inc. a ...

Gerard O’Donnell, a high performance athletics coach, specialising in sprints and hurdles, is helping the country's sprint ...

A new COVID variant, NB.1.8.1, linked to a surge in China, has been detected in the United States via international travelers ...

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron ...